These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.
Pubmed for Handhelds
PUBMED FOR HANDHELDS
Journal Abstract Search
193 related items for PubMed ID: 21175229
1. Secondary amyloidosis in a patient with long duration Crohn's disease treated with infliximab. Fidalgo C, Calado J, Cravo M. BioDrugs; 2010 Dec 14; 24 Suppl 1():15-7. PubMed ID: 21175229 [Abstract] [Full Text] [Related]
10. Infliximab in the treatment of amyloidosis secondary to Crohn's disease. Cabezuelo JB, Egea JP, Ramos F, Torrella E, Muray S, Alcázar C. Nefrologia; 2012 May 14; 32(3):385-8. PubMed ID: 22592423 [Abstract] [Full Text] [Related]
14. Complete remission of nephrotic syndrome secondary to amyloid a amyloidosis in patient with inactive Crohn's disease after treatment by infliximab. Hassani K, Hamzi MA, El Kabbaj D. Saudi J Kidney Dis Transpl; 2018 May 14; 29(2):456-461. PubMed ID: 29657220 [Abstract] [Full Text] [Related]
15. Ineffectiveness of infliximab therapy in severe infantile Crohn's disease. Uslu N, Usta Y, Saltik-Temizel IN, Demir H, Gürakan F, Ozen H, Yüce A. J Crohns Colitis; 2010 Feb 14; 4(1):106-9. PubMed ID: 21122492 [Abstract] [Full Text] [Related]
16. [Effectiveness of anti-TNF alpha antibodies in treatment of fistulizing Crohn's disease]. Rozpondek P, Zwolińska-Wcisło M, Przybylska M, Mach T. Przegl Lek; 2011 Feb 14; 68(9):602-5. PubMed ID: 22335009 [Abstract] [Full Text] [Related]